In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH chief: Flat budget a 'good' outcome, but sequestration looms

This article was originally published in Scrip

Executive Summary

Last year, in the depths of the uncertain months between the US teetering on the edge of a credit default and a congressional super committee's ultimate non-decision decision, given the dire predictions, the heads of the agencies that make up the National Institutes of Health (NIH) had expected their funding to be severely cut, and started making plans for a hit as deep as 5% (scripintelligence, 22 November 2011, 8 August 2011, 3 August 2011).

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel